EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,617,305 | -4.1% | 1,829,450 | +4.4% | 0.00% | – |
| Q2 2023 | $15,248,247 | +240.5% | 1,752,672 | +15.1% | 0.00% | – |
| Q1 2023 | $4,477,823 | -23.8% | 1,523,069 | -9.3% | 0.00% | – |
| Q4 2022 | $5,874,622 | -55.0% | 1,678,463 | +1.7% | 0.00% | – |
| Q3 2022 | $13,060,000 | +5.8% | 1,651,029 | +5.2% | 0.00% | – |
| Q2 2022 | $12,347,000 | -33.4% | 1,568,762 | +2.8% | 0.00% | – |
| Q1 2022 | $18,543,000 | +5.2% | 1,526,153 | +5.9% | 0.00% | – |
| Q4 2021 | $17,633,000 | +42.1% | 1,440,631 | +21.0% | 0.00% | – |
| Q3 2021 | $12,407,000 | +22.2% | 1,190,633 | +5.4% | 0.00% | – |
| Q2 2021 | $10,156,000 | +44056.5% | 1,129,744 | +48849.0% | 0.00% | – |
| Q1 2021 | $23,000 | -96.5% | 2,308 | -97.7% | 0.00% | – |
| Q4 2020 | $662,000 | – | 100,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |